ABSTRACT

Introduction:

Matrix metalloproteinase 2 levels are important in metastasis of cancer.

Patients and Methods:

In our study, we investigated by enzyme linked immunosorbent assay (ELISA) of the serum matrix metalloproteinase 2 levels in 86 breast cancer patients.

Results:

We were found higher in patients with liver metastasis.

Conclusion:

We suggested that serum matrix metalloproteinase 2 levels might reflect the severity of metastasis in breast cancer patients with liver metastasis.